Supplemental Materials and Methods 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

The Supplemental Materials and Methods file depicts a representative graphical report provided to participants at Visits 1 and 2 that illustrates the participant’s estimated 5-year, 10-year, and remaining lifetime breast cancer risk (determined by NCI-BCRAT and IBIS with and without PRS).